课题基金 / 基金详情

Development of an Antimicrobial Resistance Diversity Index (ARDI) to guide initiatives and investment in public health, antimicrobial stewardship and infection control

Development of an Antimicrobial Resistance Diversity Index (ARDI) to guide initiatives and investment in public health, antimicrobial stewardship and infection control
制定抗菌药物耐药性多样性指数 (ARDI)，以指导公共卫生、抗菌药物管理和感染控制方面的举措和投资
批准号：
269780
负责人：
Wu Jianhong
金额：
$14.52万
依托单位：
York University (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=269780&lang=en
关键词：
Antimicrobial Resistance Human Health 1101 Infectious Disease Mathematical Biology And Physiology 2957 Mathematical Modelling 2960 Medical And Health Sciences 1211

项目摘要

项目成果

Wu Jianhong的其他基金

相关文献

中文摘要
翻译
抗微生物细菌对一种或多种抗生素没有反应。感染这些细菌的患者住院时间更长，死亡风险更高，护理费用也更高。在加拿大，抗菌素的数量
英文摘要
Antimicrobial-resistant germs do not respond to one or more antibiotics. Patients who acquire infections from these germs have longer hospital stays, an increased risk of death, and their care is more expensive. In Canada, the number of antimicrobial-resi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文